Tolerance Bio will increase health span by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance News & UPDATES Featured Oct 27, 2025 Tolerance Bio’s Implanted iPSC-derived Thymic Organoids Enable In Vivo Positive Selection of Human T cells and Tumor Burden Reduction in Melanoma Oct 27, 2025 Read More → Oct 27, 2025 Sep 8, 2025 Tolerance Bio and ZipCode Bio Announce Strategic R&D Collaboration to Advance Targeted Thymus Therapeutics Sep 8, 2025 Read More → Sep 8, 2025 Dec 19, 2024 Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases Dec 19, 2024 Read More → Dec 19, 2024
